Abstract
Background A 33-year-old man presented with secondary infertility, increased libido, and extreme oligospermia. Testicular volumes were reduced, but no gynecomastia was apparent and androgen abuse was denied.
Investigations Physical examination, semen-volume and sperm-density assessment, laboratory tests for serum levels of luteinizing hormone, follicle-stimulating hormone, testosterone, and dehydroepiandrosterone sulfate, karyotyping, testicular ultrasound, pelvic and abdominal CT, assessment for serum testicular tumor markers (α-fetoprotein and human chorionic gonadotropin), and histologic examination of testicular tissue.
Diagnosis Benign Leydig-cell adenoma.
Management Left orchidectomy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kim I et al. (1985) Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol 9: 177–192
Liu G et al. (1999) Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341: 1731–1736
Carvajal-Carmona LG et al. (2006) Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations. J Clin Endocrinol Metab 91: 3071–3075
Caron PJ et al. (1994) Luteinizing hormone secretory pattern before and after removal of Leydig cell tumor of the testis. Eur J Endocrinol 131: 156–159
Kuhn JM et al. (1994) Evidence of oestradiol-induced changes in gonadotrophin secretion in men with feminizing Leydig cell tumours. Eur J Endocrinol 131: 160–166
Carmignani L et al. (2005) Prognostic parameters in adult impalpable ultrasonographic lesions of the testicle. J Urol 174: 1035–1038
Fallick ML et al. (1999) Leydig cell tumors presenting as azoospermia. J Urol 161: 1571–1572
Zhengwei Y et al. (1998) Stereological evaluation of human spermatogenesis after suppression by testosterone treatment: heterogeneous pattern of spermatogenic impairment. J Clin Endocrinol Metab 83: 1284–1291
Mostafid H et al. (1998) Leydig cell tumour of the testis: a rare cause of male infertility. Br J Urol 81: 651
Kuhn JM et al. (1987) Evaluation of diagnostic criteria for Leydig cell tumours in adult men revealed by gynaecomastia. Clin Endocrinol (Oxf) 26: 407–416
Buckley WE et al. (1988) Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 260: 3441–3445
Death AK et al. (2004) Tetrahydrogestrinone is a potent androgen and progestin. J Clin Endocrinol Metab 89: 2498–2500
Gazvani MR et al. (1997) Conservative management of azoospermia following steroid abuse. Hum Reprod 12: 1706–1708
Lefebvre H et al. (1993) A hCG-secreting testicular seminoma revealed by male infertility: mechanism of hCG-evoked endocrine disturbances. Andrologia 25: 283–287
Stikkelbroeck NM et al. (2001) High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86: 5721–5728
Kuhn JM et al. (2002) Cosecretion of estrogen and inhibin B by a feminizing adrenocortical adenoma: impact on gonadotropin secretion. J Clin Endocrinol Metab 87: 2367–2375
Akman H et al. (2003) Incidental bilateral leydig cell tumor of the testes. Urol Int 71: 316–318
Steiner H et al. (2003) Frozen section analysis-guided organ-sparing approach in testicular tumors: technique, feasibility, and long-term results. Urology 62: 508–513
Acknowledgements
RI McLachlan is supported by an Australian National Health and Medical Research Council Fellowship #169020 and Program Grant #241000, DM de Kretser is supported by National Health and Medical Research Program Grant # 334011.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
McLachlan, R., de Kretser, D. Hypogonadotropism with elevated serum testosterone: reversible causes of secondary infertility. Nat Rev Urol 3, 560–565 (2006). https://doi.org/10.1038/ncpuro0585
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0585